BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32165496)

  • 1. Long noncoding RNA
    Yoneda R; Ueda N; Uranishi K; Hirasaki M; Kurokawa R
    J Biol Chem; 2020 Apr; 295(17):5626-5639. PubMed ID: 32165496
    [No Abstract]   [Full Text] [Related]  

  • 2. Arginine methylation of translocated in liposarcoma (TLS) inhibits its binding to long noncoding RNA, abrogating TLS-mediated repression of CBP/p300 activity.
    Cui W; Yoneda R; Ueda N; Kurokawa R
    J Biol Chem; 2018 Jul; 293(28):10937-10948. PubMed ID: 29784880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding specificity of Translocated in LipoSarcoma/FUsed in Sarcoma with lncRNA transcribed from the promoter region of cyclin D1.
    Yoneda R; Suzuki S; Mashima T; Kondo K; Nagata T; Katahira M; Kurokawa R
    Cell Biosci; 2016; 6():4. PubMed ID: 26816614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter-associated long noncoding RNAs repress transcription through a RNA binding protein TLS.
    Kurokawa R
    Adv Exp Med Biol; 2011; 722():196-208. PubMed ID: 21915790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA sequence and length contribute to RNA-induced conformational change of TLS/FUS.
    Hamad N; Mashima T; Yamaoki Y; Kondo K; Yoneda R; Oyoshi T; Kurokawa R; Nagata T; Katahira M
    Sci Rep; 2020 Feb; 10(1):2629. PubMed ID: 32060318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. m
    Yoneda R; Ueda N; Kurokawa R
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Promoter-Associated Noncoding RNA
    Palombo R; Frisone P; Fidaleo M; Mercatelli N; Sette C; Paronetto MP
    Cancer Res; 2019 Jul; 79(14):3570-3582. PubMed ID: 31072811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter-associated noncoding RNA from the CCND1 promoter.
    Song X; Wang X; Arai S; Kurokawa R
    Methods Mol Biol; 2012; 809():609-22. PubMed ID: 22113303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a mouse monoclonal antibody for the detection of asymmetric dimethylarginine of Translocated in LipoSarcoma/FUsed in Sarcoma and its application in analyzing methylated TLS.
    Fujimoto K; Kurokawa R
    Cell Biosci; 2014; 4():77. PubMed ID: 25810899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00473 mediates cyclin D1 expression through a balance between activation and repression signals in breast cancer cells.
    Shi X; Wang X
    FEBS Lett; 2019 Apr; 593(7):751-759. PubMed ID: 30848493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis.
    Chang W; Wang Y; Li W; Geng Z
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of the oncogene lncRNA NEAT1 restores the availability of
    Hu Y; Yang Q; Wang L; Wang S; Sun F; Xu D; Jiang J
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
    Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
    J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.
    Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y
    Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial ncRNA targeting induces cell cycle arrest and tumor growth inhibition of MDA-MB-231 breast cancer cells through reduction of key cell cycle progression factors.
    Fitzpatrick C; Bendek MF; Briones M; Farfán N; Silva VA; Nardocci G; Montecino M; Boland A; Deleuze JF; Villegas J; Villota C; Silva V; Lobos-Gonzalez L; Borgna V; Barrey E; Burzio LO; Burzio VA
    Cell Death Dis; 2019 May; 10(6):423. PubMed ID: 31142736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of Hotair suppresses proliferation and cell cycle progression in hepatocellular carcinoma cell by downregulating CCND1 expression.
    Zhou JJ; Cheng D; He XY; Meng Z; Li WZ; Chen RF
    Mol Med Rep; 2017 Oct; 16(4):4980-4986. PubMed ID: 28791413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m
    Bian Y; Wang Y; Xu S; Gao Z; Li C; Fan Z; Ding J; Wang K
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription.
    Wang X; Arai S; Song X; Reichart D; Du K; Pascual G; Tempst P; Rosenfeld MG; Glass CK; Kurokawa R
    Nature; 2008 Jul; 454(7200):126-30. PubMed ID: 18509338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA FOXD2-AS1 regulates chondrocyte proliferation in osteoarthritis by acting as a sponge of miR-206 to modulate CCND1 expression.
    Cao L; Wang Y; Wang Q; Huang J
    Biomed Pharmacother; 2018 Oct; 106():1220-1226. PubMed ID: 30119190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Chain Non-Coding RNA (lncRNA) HOTAIR Knockdown Increases miR-454-3p to Suppress Gastric Cancer Growth by Targeting STAT3/Cyclin D1.
    Jiang D; Li H; Xiang H; Gao M; Yin C; Wang H; Sun Y; Xiong M
    Med Sci Monit; 2019 Feb; 25():1537-1548. PubMed ID: 30810117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.